Our results demonstrate that MKP-2 is a major regulator of p38 MAPK, JNK, and ERK activities in insulin responsive tissues, and upregulation of MKP-2 in obesity contributes to the development of insulin resistance, fatty liver disease, and metabolic dysfunction. Here, DUSP4 is linked to fatty liver disease.